We postulated that increased LDLR H3-K36me3 could be recognized by MRG15, which in turn could recruit polypyrimidine tract-binding protein (PTB) to affect the alternative splicing of LDLR pre-mRNA in hypercholesterolemia (Figure 6). The gene discussed is PTBP1; the disease is familial hypercholesterolemia.